121 related articles for article (PubMed ID: 11336399)
1. Sensitivity and specificity of denaturing high-pressure liquid chromatography for unknown protein C gene mutations.
Taliani MR; Roberts SC; Dukek BA; Pruthi RK; Nichols WL; Heit JA
Genet Test; 2001; 5(1):39-44. PubMed ID: 11336399
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and application of denaturing HPLC for mutation detection in Marfan syndrome: Identification of 20 novel mutations and two novel polymorphisms in the FBN1 gene.
Mátyás G; De Paepe A; Halliday D; Boileau C; Pals G; Steinmann B
Hum Mutat; 2002 Apr; 19(4):443-56. PubMed ID: 11933199
[TBL] [Abstract][Full Text] [Related]
3. DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations.
Klein B; Weirich G; Brauch H
Hum Genet; 2001 May; 108(5):376-84. PubMed ID: 11409863
[TBL] [Abstract][Full Text] [Related]
4. A high-throughput denaturing high-performance liquid chromatography method for the identification of variant alleles associated with dihydropyrimidine dehydrogenase deficiency.
Ezzeldin H; Okamoto Y; Johnson MR; Diasio RB
Anal Biochem; 2002 Jul; 306(1):63-73. PubMed ID: 12069415
[TBL] [Abstract][Full Text] [Related]
5. NF1 gene analysis based on DHPLC.
De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
[TBL] [Abstract][Full Text] [Related]
6. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.
Shabbeer J; Robinson M; Desnick RJ
Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228
[TBL] [Abstract][Full Text] [Related]
7. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection.
O'Donovan MC; Oefner PJ; Roberts SC; Austin J; Hoogendoorn B; Guy C; Speight G; Upadhyaya M; Sommer SS; McGuffin P
Genomics; 1998 Aug; 52(1):44-9. PubMed ID: 9740670
[TBL] [Abstract][Full Text] [Related]
8. Assessment of denaturing high-performance liquid chromatography (DHPLC) in screening for mutations in connexin 26 (GJB2).
Lin D; Goldstein JA; Mhatre AN; Lustig LR; Pfister M; Lalwani AK
Hum Mutat; 2001; 18(1):42-51. PubMed ID: 11438992
[TBL] [Abstract][Full Text] [Related]
9. DHPLC screening of cystic fibrosis gene mutations.
Ravnik-Glavac M; Atkinson A; Glavac D; Dean M
Hum Mutat; 2002 Apr; 19(4):374-83. PubMed ID: 11933191
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of denaturing high performance liquid chromatography for the mutational analysis of the MEN1 gene.
Crépin M; Pigny P; Escande F; Bauters CC; Calender A; Lefevre S; Buisine MP; Porchet N; Odou MF
J Mol Endocrinol; 2006 Apr; 36(2):369-76. PubMed ID: 16595707
[TBL] [Abstract][Full Text] [Related]
11. A complete mutation screen of the ADPKD genes by DHPLC.
Rossetti S; Chauveau D; Walker D; Saggar-Malik A; Winearls CG; Torres VE; Harris PC
Kidney Int; 2002 May; 61(5):1588-99. PubMed ID: 11967008
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of denaturing high-performance liquid chromatography as a rapid detection method for identification of epidermal growth factor receptor mutations in nonsmall-cell lung cancer.
Cohen V; Agulnik JS; Jarry J; Batist G; Small D; Kreisman H; Tejada NA; Miller WH; Chong G
Cancer; 2006 Dec; 107(12):2858-65. PubMed ID: 17096434
[TBL] [Abstract][Full Text] [Related]
13. Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations.
Liu W; Smith DI; Rechtzigel KJ; Thibodeau SN; James CD
Nucleic Acids Res; 1998 Mar; 26(6):1396-400. PubMed ID: 9490783
[TBL] [Abstract][Full Text] [Related]
14. [Denaturing high-performance liquid chromatography for screening antithrombin III gene mutation and polymorphisms in patients with cerebral venous thrombosis].
Wang LP; Qiu YW; Yin AL; Ma YY; Liu KL; Xiong L; Yu YH; Zhong M; Wang C
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):1982-6. PubMed ID: 19861246
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis using DHPLC of cystic fibrosis: increase of the mutation detection rate among the affected population in Central Italy.
D'Apice MR; Gambardella S; Bengala M; Russo S; Nardone AM; Lucidi V; Sangiuolo F; Novelli G
BMC Med Genet; 2004 Apr; 5():8. PubMed ID: 15084222
[TBL] [Abstract][Full Text] [Related]
16. Denaturing high performance liquid chromatography: high throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neurone disease.
Yu B; Sawyer NA; Caramins M; Yuan ZG; Saunderson RB; Pamphlett R; Richmond DR; Jeremy RW; Trent RJ
J Clin Pathol; 2005 May; 58(5):479-85. PubMed ID: 15858117
[TBL] [Abstract][Full Text] [Related]
17. Novel mutations of dystrophin gene in DMD patients detected by rapid scanning in biplex exons DHPLC analysis.
Muscarella LA; Piemontese MR; Barbano R; Fazio A; Guarnieri V; Quattrone A; Zelante L
Biomol Eng; 2007 Jun; 24(2):231-6. PubMed ID: 17145200
[TBL] [Abstract][Full Text] [Related]
18. Reliability of DHPLC in mutational screening of beta-globin (HBB) alleles.
Colosimo A; Guida V; De Luca A; Cappabianca MP; Bianco I; Palka G; Dallapiccola B
Hum Mutat; 2002 Mar; 19(3):287-95. PubMed ID: 11857746
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography.
van Den Bosch BJ; de Coo RF; Scholte HR; Nijland JG; van Den Bogaard R; de Visser M; de Die-Smulders CE; Smeets HJ
Nucleic Acids Res; 2000 Oct; 28(20):E89. PubMed ID: 11024191
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF.
Houdayer C; Gauthier-Villars M; Laugé A; Pagès-Berhouet S; Dehainault C; Caux-Moncoutier V; Karczynski P; Tosi M; Doz F; Desjardins L; Couturier J; Stoppa-Lyonnet D
Hum Mutat; 2004 Feb; 23(2):193-202. PubMed ID: 14722923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
